Form 4: AN2 Therapeutics Director Buys Shares
Insider Transaction (Form 4)
Margaret M Fitzpatrick, a Director of AN2 Therapeutics, Inc., purchased 2,098 shares of common stock on September 1, 2026 for $5.53 per share.
Summary
- Open-market purchase: acquired 2,098 Common Stock at $5.53 ($11,602) on September 1, 2026; holds 10,708 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $11,602, committing personal capital to the stock.
Insider Transactions
Margaret M Fitzpatrick — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Open-market purchase | Common Stock | 2,098 | $6 | $11.6K | 10,708 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Open-market purchase (2,098 shares) |
Keywords
insider transaction, Form 4, ANTX, AN2 Therapeutics, Inc., bullish, Margaret M Fitzpatrick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.